Page 90 - Looking Statement News Today

Press release content from Business Wire. The AP news staff was not involved in its creation.

VANCOUVER, BRITISH COLUMBIA TheNewswire – January 25, 2021 US Newrange Gold Corp. is pleased to announce that the Company has initiated a 52 line kilometer IP and Resistivity survey being conducted by Géophysique TMC of Val-d’Or, Quebec at the Company’s Pamlico project in Nevada. The survey is designed to expand and increase resolution of the large “Line 5” chargeability anomaly and a separate but … (TheNewswire) VANCOUVER, BRITISH COLUMBIA TheNewswire – January 25, 2021 (TSXV:...

Press release content from Business Wire. The AP news staff was not involved in its creation. Merck Announces U.S. FDA Approval of VERQUVO® (vericiguat) January 20, 2021 GMT KENILWORTH, N.J.--(BUSINESS WIRE)--Jan 20, 2021-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved VERQUVO, a soluble guanylate cyclase (sGC) stimulator, to reduce the risk of cardiovascular death and heart failure hospitaliza...

Dallas-basedEnergy Transfer LP today announced the first Very Large Ethane Carrier (VLEC) has been loaded under its previously announced joint...

Press release content from Accesswire. The AP news staff was not involved in its creation. Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study January 20, 2021 GMT TORONTO, ON / ACCESSWIRE / January 20, 2021 / Theralase® Technologies Inc. (“Theralase” or “Company”) (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (“PDC”) and their associa...

Theralase Technologies Inc.: Theralase Launches Second Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that Urology Associates P.C. (" UA") has received site Institutional Review Board ...

Posted on 399 Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced the launch of the Omnipod DASH ® Insulin Management System (Omnipod DASH System) in Canada. “We’re thrilled to bring this convenient and easy-to-use insulin delivery system to Canada,” said Bret Christensen, Chief Commerc...

Theralase Technologies Inc.: Theralase Launches First Clinical Study Site in the US for Phase II Bladder Cancer Clinical Study TSXV:TLT)( OTCQB:TLTFF), a clinical stage pharmaceutical company focused on the research and development of light activated Photo Dynamic Compounds (" PDC") and their associated drug formulations used to safely and effectively destroy various cancers, bacteria and viruses announced today that Virginia Urology (" VU") has received site Institutional Review Board (" IRB")...

Newrange Concludes Sales of Colombian Assets and Advances Property Options for North Birch Project TSXV:NRG ) Newrange Gold Corp. is pleased to provide the following corporate update The Company has exercised its option to acquire a 100% interest in the H Lake Property, which forms the western portion of its North Birch Project east of Red Lake, Ontario.  Pursuant to the Option Agreement signed with Bounty Gold Corp. on January 13, 2020, Newrange has paid a total of $50,000 in cash and issued ...

ACTON, Mass.--(BUSINESS WIRE)--Jan 18, 2021--